65,437 trials
Mild Cognitive Impairment, Lewy Body Dementia, Parkinson's Disease Rapid Eye Movement Sleep Behavior Disorder, Parkinson's Disease Dementia
Primary: Change From Baseline in Negative Emotional Bias in the Facial Expression Recognition Task (FERT) — 8.1316; 13.6138; 8.0168; 6.7407 Percent change — p=0.0479
Preterm Birth · Tube Feeding · Swallowing Disorder
Primary: Transition Time to Full Oral Feeding — 10; 9 days
Central Retinal Vein Occlusion
Primary: Incidence and Severity of Ocular and Systemic Adverse Events — 1; 0; 0; 1 participants
Chronic Spontaneous Urticaria
Primary: Change From Baseline in Weekly Urticaria Score (UAS7) at Week 12 (Scenario 1 With UAS7 as Primary Efficacy Endpoint) — -20.02; -13.79 Scores on a scale — p=<0.001
Cancer Pain
Primary: To Compare the Time to Readiness for Discharge From PACU (Minutes) After Port-a-Cath Placement Surgery Between Patients Who Are Randomized to Receive Intraoperative…
Exercise Therapy · Heart Rate Determination
Primary: Provider Behavior — 0.38; 0.48; 0.62; 1.43 observations — p=0.73
Hematologic Malignancy
Primary: Feasibility as Measured by Number of Participants Accrued to Single-arm Pilot — 32 Participants
IVF · Infertility
Primary: Clinical Pregnancy Rate — 257; 248 Participants
Healthy Volunteers
Primary: Maximum Observed Concentration (Cmax) of BOS — 692.9; 604.1 picograms per milliliter (pg/mL)
Diabetes Mellitus, Type 2
Primary: Change in A1C at Week 22 — -1.5; 1.0 percentage of glycated hemoglobin
Covid19
Primary: All Case Mortality by Day 28 — 52; 5; 30; 17 participants
Ametropia · Myopia · Hyperopia
Primary: Percentage of Lenses With Axis Orientation Within Plus or Minus 30 Degrees From the Intended Axis at 10 Minutes After Lens Insertion — 100.0; 100.0 percentage of lenses
Burn Scar · Skin Graft Scar
Primary: Contracture of Scar Surface Area (Percentage of Original Area) — 97; 97 percentage
Hip Arthropathy
Primary: Survival Rate of Stems — 94 Percentage of stem unrevised
Gestational Diabetes · Diabetes, Gestational · Pregnancy in Diabetes
Primary: Proportion of Women Who Are Eligible, Screened, Enroll and Remain in the Study — 25; 26 Participants — p=0.9